Does preoperative neoadjuvant chemotherapy impact short-term surgical outcomes in patients with locally advanced colon cancer?

Ryan Silva, Mohammad Hamidi, Pamela Omesiete, Fawsia Osman, Casey Charlton, Shoujit Banerjee, Timothy Estrada, Valentine Nfonsam

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Background: Preoperative neoadjuvant chemotherapy (NAC) for colon cancer in advanced stages is associated with improved outcomes and tumor regression. The aim of our study was to identify outcomes in patients with colon cancer who received preoperative NAC. Methods: A 4-year analysis of the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) was performed. We included patients with locally advanced colon cancer (non-metastatic T3, T4 with or without nodal involvement) who underwent colon cancer resection. Patients were stratified into two groups (NAC and No-NAC). Our outcome measures were anastomotic leaks, hospital length of stay (LOS), 30-day complications, 30-day mortality, and 30-day readmissions. We performed a multi-variable logistic regression analysis. Results: We analyzed 90,055 patients of which 7694 (NAC: 7.8 % (n = 599) and No-NAC: 92.2% (n = 7095)) met the inclusion criteria and included in the analysis. Mean age was 67 ± 13 years, 51% were males, and 72% were whites. Patients in the NAC group were more likely to be younger (60 ± 12 years vs. 68 ± 13 years, p < 0.01) and males (62% vs. 50%, p < 0.01) compared to No-NAC. On regression analysis, preoperative NAC was independently associated with higher odds of anastomotic leak (OR 1.35 [1.05–1.97], p = 0.03) and 30-day readmission (OR 1.54 [1.24–2.05], p < 0.01) in reference to No-NAC. However, no association was found between NAC and 30-day complications and 30-day mortality. Conclusions: Preoperative NAC might be associated with adverse outcomes of anastomotic leaks and 30-day readmissions, however does not appear to impact 30-day complications nor 30-day mortality.

Original languageEnglish (US)
Pages (from-to)2127-2134
Number of pages8
JournalInternational Journal of Colorectal Disease
Issue number10
StatePublished - Oct 2021


  • Colon cancer
  • Locally advanced
  • Neoadjuvant
  • chemotherapy

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Does preoperative neoadjuvant chemotherapy impact short-term surgical outcomes in patients with locally advanced colon cancer?'. Together they form a unique fingerprint.

Cite this